Home
ELTX
ELTX News

Latest Elicio Therapeutics Inc. (ELTX) News on November 28, 2025

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer

GlobeNewswire

8 days ago

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer

Associated Press Finance

14 days ago

Elicio Therapeutics: Q3 Earnings Snapshot

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

14 days ago

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight

GlobeNewswire

15 days ago

KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight

Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC

GlobeNewswire

20 days ago

Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer

GlobeNewswire

5 months ago

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer

MT Newswires

6 months ago

Elicio Therapeutics Gets $10 Million Note Financing

Elicio Therapeutics Secures $10 Million in Financing

GlobeNewswire

6 months ago

Elicio Therapeutics Secures $10 Million in Financing

Associated Press Finance

6 months ago

Elicio Therapeutics: Q1 Earnings Snapshot

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

6 months ago

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher

Zacks

7 months ago

Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

GlobeNewswire

7 months ago

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

MT Newswires

8 months ago

Top Premarket Gainers

Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year?

Zacks

8 months ago

Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's What You Should Know

Zacks

8 months ago

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's What You Should Know

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

8 months ago

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

MT Newswires

8 months ago

Elicio Therapeutics Names Preetam Shah CFO

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

GlobeNewswire

8 months ago

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

With 36% ownership, Elicio Therapeutics, Inc. (NASDAQ:ELTX) insiders have a lot at stake

Simply Wall St.

8 months ago

With 36% ownership, Elicio Therapeutics, Inc. (NASDAQ:ELTX) insiders have a lot at stake

Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025

Insider Monkey

10 months ago

Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

10 months ago

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

GlobeNewswire

10 months ago

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

Elicio Therapeutics Advances ELI-002 and Secures Funding

TipRanks

a year ago

Elicio Therapeutics Advances ELI-002 and Secures Funding

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

GlobeNewswire

a year ago

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

GlobeNewswire

a year ago

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Associated Press Finance

a year ago

Elicio Therapeutics: Q3 Earnings Snapshot

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

a year ago

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting

GlobeNewswire

a year ago

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

GlobeNewswire

a year ago

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

All You Need to Know About Elicio Therapeutics (ELTX) Rating Upgrade to Strong Buy

Zacks

a year ago

All You Need to Know About Elicio Therapeutics (ELTX) Rating Upgrade to Strong Buy

Elicio Therapeutics Reports Inducement Grants

GlobeNewswire

a year ago

Elicio Therapeutics Reports Inducement Grants

Elicio Therapeutics Reports Inducement Grants

GlobeNewswire

a year ago

Elicio Therapeutics Reports Inducement Grants

GlobeNewswire

a year ago

Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines

Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

a year ago

Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

a year ago

Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note

GlobeNewswire

a year ago

Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note

MT Newswires

a year ago

Elicio Therapeutics Stock Falls After $11.5 Million Underwritten Public Offering Priced

Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering

GlobeNewswire

a year ago

Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering

MT Newswires

a year ago

Elicio Therapeutics Launches Public Offering; Shares Tumble After-Hours

Elicio Therapeutics Announces Proposed Public Offering

GlobeNewswire

a year ago

Elicio Therapeutics Announces Proposed Public Offering

Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P

GlobeNewswire

a year ago

Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P

Elicio Therapeutics Reports Inducement Grants

GlobeNewswire

a year ago

Elicio Therapeutics Reports Inducement Grants

Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

GlobeNewswire

2 years ago

Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

BayWa r.e. and Elicio to build 270MW floating wind farm in France

Power Technology

2 years ago

BayWa r.e. and Elicio to build 270MW floating wind farm in France

Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

2 years ago

Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

GlobeNewswire

2 years ago

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

Robert Connelly Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) CEO is the most bullish insider, and their stock value gained 11%last week

Simply Wall St.

2 years ago

Robert Connelly Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) CEO is the most bullish insider, and their stock value gained 11%last week

Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting

GlobeNewswire

2 years ago

Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

GlobeNewswire

2 years ago

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

Elicio Therapeutics Announces $6.0 Million Private Placement Financing

GlobeNewswire

2 years ago

Elicio Therapeutics Announces $6.0 Million Private Placement Financing

Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

2 years ago

Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

2 years ago

Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

CompoSecure, Inc. (NASDAQ:CMPO) Shares Could Be 46% Below Their Intrinsic Value Estimate

Simply Wall St.

2 years ago

CompoSecure, Inc. (NASDAQ:CMPO) Shares Could Be 46% Below Their Intrinsic Value Estimate

GSI Technology, Inc. (NASDAQ:GSIT) Q3 2024 Earnings Call Transcript

Insider Monkey

2 years ago

GSI Technology, Inc. (NASDAQ:GSIT) Q3 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2024 GSI Technology Inc Earnings Call

Associated Press Finance

2 years ago

GSI Technology: Fiscal Q3 Earnings Snapshot

GSI Technology, Inc. Reports Third Quarter Fiscal 2024 Results

GlobeNewswire

2 years ago

GSI Technology, Inc. Reports Third Quarter Fiscal 2024 Results

Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Business Wire

2 years ago

Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors

GlobeNewswire

2 years ago

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors

D-Wave Appoints Former Secretary of Homeland Security to Board

NewMediaWire

2 years ago

D-Wave Appoints Former Secretary of Homeland Security to Board

AMERISERV FINANCIAL REPORTS EARNINGS FOR THE FULL YEAR OF 2023 AND ANNOUNCES QUARTERLY COMMON STOCK CASH DIVIDEND

PR Newswire

2 years ago

AMERISERV FINANCIAL REPORTS EARNINGS FOR THE FULL YEAR OF 2023 AND ANNOUNCES QUARTERLY COMMON STOCK CASH DIVIDEND

Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week, benefiting both individual investors who own 39% as well as institutions

Simply Wall St.

2 years ago

Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week, benefiting both individual investors who own 39% as well as institutions

Scienjoy to Participate and Present in Two Upcoming Investor Conferences

PR Newswire

2 years ago

Scienjoy to Participate and Present in Two Upcoming Investor Conferences

5E Advanced Materials Closes First Tranche of Equity Financing Following Special Meeting

GlobeNewswire

2 years ago

5E Advanced Materials Closes First Tranche of Equity Financing Following Special Meeting

Universal Electronics Announces U.S. Court of Appeals Affirms Ban on Import and Sale of Roku Infringing Products

Business Wire

2 years ago

Universal Electronics Announces U.S. Court of Appeals Affirms Ban on Import and Sale of Roku Infringing Products

SurgePays Announces Pricing of $15 Million Public Offering

GlobeNewswire

2 years ago

SurgePays Announces Pricing of $15 Million Public Offering

GlobeNewswire

2 years ago

Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to February 13, 2024

Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium

GlobeNewswire

2 years ago

Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

InvestorPlace

2 years ago

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire

2 years ago

Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference

Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study

GlobeNewswire

2 years ago

Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study

GSI Technology to Announce Fiscal Third Quarter 2024 Results on January 25, 2024

GlobeNewswire

2 years ago

GSI Technology to Announce Fiscal Third Quarter 2024 Results on January 25, 2024

Are Robust Financials Driving The Recent Rally In Perma-Pipe International Holdings, Inc.'s (NASDAQ:PPIH) Stock?

Simply Wall St.

2 years ago

Are Robust Financials Driving The Recent Rally In Perma-Pipe International Holdings, Inc.'s (NASDAQ:PPIH) Stock?

New Opportunity for Residential Broadband Service Providers: High Throughput, Managed Wi-Fi Mesh with Value Added Services

PR Newswire

2 years ago

New Opportunity for Residential Broadband Service Providers: High Throughput, Managed Wi-Fi Mesh with Value Added Services

Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002

GlobeNewswire

2 years ago

Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002

Fraud, Data Breaches and Password Crisis Drive CompoSecure’s Vision for the Future of Payment Security: CEO Predicts Next Generation of Payment Cards in 2024

GlobeNewswire

2 years ago

Fraud, Data Breaches and Password Crisis Drive CompoSecure’s Vision for the Future of Payment Security: CEO Predicts Next Generation of Payment Cards in 2024

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

InvestorPlace

2 years ago

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, and March 2024 of $0.0603 Per Share

ACCESSWIRE

2 years ago

Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, and March 2024 of $0.0603 Per Share

ACCESSWIRE

2 years ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Perma-Pipe International Holdings announces acceptance into QatarEnergy’s Tawteen Program

Business Wire

2 years ago

Perma-Pipe International Holdings announces acceptance into QatarEnergy’s Tawteen Program

GSI Technology Receives Award from U.S. Air Force Research Laboratory to Demonstrate High-Data Computation Use Cases Leveraging Its Next-Generation APU

GlobeNewswire

2 years ago

GSI Technology Receives Award from U.S. Air Force Research Laboratory to Demonstrate High-Data Computation Use Cases Leveraging Its Next-Generation APU

RCM Technologies, Inc. (RCMT) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

2 years ago

RCM Technologies, Inc. (RCMT) is on the Move, Here's Why the Trend Could be Sustainable

Live Ventures Incorporated (NASDAQ:LIVE) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Live Ventures Incorporated (NASDAQ:LIVE) Q4 2023 Earnings Call Transcript

Elicio Therapeutics Announces $7.0 Million Private Placement Financing

GlobeNewswire

2 years ago

Elicio Therapeutics Announces $7.0 Million Private Placement Financing

Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

GlobeNewswire

2 years ago

Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

GSI Technology to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9 and 10, 2024

GlobeNewswire

2 years ago

GSI Technology to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9 and 10, 2024

GlobeNewswire

2 years ago

Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to January 13, 2024

Perma-Pipe International Holdings (NASDAQ:PPIH) Is Experiencing Growth In Returns On Capital

Simply Wall St.

2 years ago

Perma-Pipe International Holdings (NASDAQ:PPIH) Is Experiencing Growth In Returns On Capital

Caleres (NYSE:CAL) Will Pay A Dividend Of $0.07

Simply Wall St.

2 years ago

Caleres (NYSE:CAL) Will Pay A Dividend Of $0.07

Perma-Pipe International Holdings, Inc. Announces its Third Quarter Fiscal 2023 Financial Results

Business Wire

2 years ago

Perma-Pipe International Holdings, Inc. Announces its Third Quarter Fiscal 2023 Financial Results

Safety Shot Provides Update on Litigation

GlobeNewswire

2 years ago

Safety Shot Provides Update on Litigation

Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

GlobeNewswire

2 years ago

Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Smart Share Global Limited (NASDAQ:EM) About To Shift From Loss To Profit

Simply Wall St.

2 years ago

Smart Share Global Limited (NASDAQ:EM) About To Shift From Loss To Profit

Executive Chairman Daniel Coombs Acquires 30,000 Shares of PureCycle Technologies Inc

GuruFocus.com

2 years ago

Executive Chairman Daniel Coombs Acquires 30,000 Shares of PureCycle Technologies Inc

Complete Solaria Reports Third Quarter 2023 Results

GlobeNewswire

2 years ago

Complete Solaria Reports Third Quarter 2023 Results

GlobeNewswire

2 years ago

Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to December 13, 2023

GuruFocus.com

2 years ago

Maui Land & Pineapple Co Inc Reports Q3 2023 Results Amidst Challenges

3 Penny Stocks With Potential to 10x in 2024

InvestorPlace

2 years ago

3 Penny Stocks With Potential to 10x in 2024

Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

GlobeNewswire

2 years ago

Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Eagle Delays Third Quarter 2023 Results and Conference Call

GlobeNewswire

2 years ago

Eagle Delays Third Quarter 2023 Results and Conference Call

Share on Social Networks: